115 related articles for article (PubMed ID: 34660840)
21. Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.
Violante S; Achetib N; van Roermund CWT; Hagen J; Dodatko T; Vaz FM; Waterham HR; Chen H; Baes M; Yu C; Argmann CA; Houten SM
FASEB J; 2019 Mar; 33(3):4355-4364. PubMed ID: 30540494
[TBL] [Abstract][Full Text] [Related]
22. Novel ACOX1 mutations in two siblings with peroxisomal acyl-CoA oxidase deficiency.
Morita A; Enokizono T; Ohto T; Tanaka M; Watanabe S; Takada Y; Iwama K; Mizuguchi T; Matsumoto N; Morita M; Takashima S; Shimozawa N; Takada H
Brain Dev; 2021 Mar; 43(3):475-481. PubMed ID: 33234382
[TBL] [Abstract][Full Text] [Related]
23. Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels.
Sá MJ; Rocha JC; Almeida MF; Carmona C; Martins E; Miranda V; Coutinho M; Ferreira R; Pacheco S; Laranjeira F; Ribeiro I; Fortuna AM; Lacerda L
JIMD Rep; 2016; 26():53-60. PubMed ID: 26303611
[TBL] [Abstract][Full Text] [Related]
24. Typical cMRI pattern as diagnostic clue for D-bifunctional protein deficiency without apparent biochemical abnormalities in plasma.
Grønborg S; Krätzner R; Spiegler J; Ferdinandusse S; Wanders RJ; Waterham HR; Gärtner J
Am J Med Genet A; 2010 Nov; 152A(11):2845-9. PubMed ID: 20949532
[TBL] [Abstract][Full Text] [Related]
25. D-bifunctional protein deficiency: a cause of neonatal onset seizures and hypotonia.
Nascimento J; Mota C; Lacerda L; Pacheco S; Chorão R; Martins E; Garrido C
Pediatr Neurol; 2015 May; 52(5):539-43. PubMed ID: 25882080
[TBL] [Abstract][Full Text] [Related]
26. Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiency.
Nimmo GAM; Ejaz R; Cordeiro D; Kannu P; Mercimek-Andrews S
Am J Med Genet A; 2018 Feb; 176(2):399-403. PubMed ID: 29193829
[TBL] [Abstract][Full Text] [Related]
27. A Homozygous Missense Variant in
Özkan Kart P; Sahin Y; Yildiz N; Cebi AH; Esenulku G; Cansu A
Mol Syndromol; 2024 Mar; 15(2):143-148. PubMed ID: 38585549
[TBL] [Abstract][Full Text] [Related]
28. Exome sequencing reveals a novel WDR45 frameshift mutation and inherited POLR3A heterozygous variants in a female with a complex phenotype and mixed brain MRI findings.
Khalifa M; Naffaa L
Eur J Med Genet; 2015 Aug; 58(8):381-6. PubMed ID: 26096995
[TBL] [Abstract][Full Text] [Related]
29. Clinical consequences of defects in peroxisomal beta-oxidation.
Clayton PT
Biochem Soc Trans; 2001 May; 29(Pt 2):298-305. PubMed ID: 11356171
[TBL] [Abstract][Full Text] [Related]
30. Progressive Early-Onset Leukodystrophy Related to Biallelic Variants in the
Vargas A; Rojas J; Aivasovsky I; Vergara S; Castellanos M; Prieto C; Celis L
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260297
[TBL] [Abstract][Full Text] [Related]
31. Neurodegeneration in D-bifunctional protein deficiency: diagnostic clues and natural history using serial magnetic resonance imaging.
Khan A; Wei XC; Snyder FF; Mah JK; Waterham H; Wanders RJ
Neuroradiology; 2010 Dec; 52(12):1163-6. PubMed ID: 20848092
[TBL] [Abstract][Full Text] [Related]
32. Pitfall in metabolic screening in a patient with fatal peroxisomal beta-oxidation defect.
Rosewich H; Waterham HR; Wanders RJ; Ferdinandusse S; Henneke M; Hunneman D; Gärtner J
Neuropediatrics; 2006 Apr; 37(2):95-8. PubMed ID: 16773508
[TBL] [Abstract][Full Text] [Related]
33. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
34. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
35. Uncertain significance mutation in the POLR3B gene in a Syrian boy with leukodystrophy: a case report.
Hamdan Z; Alasmar D
Ann Med Surg (Lond); 2023 Aug; 85(8):4126-4130. PubMed ID: 37554900
[TBL] [Abstract][Full Text] [Related]
36. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
37. Ataxia associated with increased plasma concentrations of pristanic acid, phytanic acid and C27 bile acids but normal fibroblast branched-chain fatty acid oxidation.
Clayton PT; Johnson AW; Mills KA; Lynes GW; Wilson J; Casteels M; Mannaerts G
J Inherit Metab Dis; 1996; 19(6):761-8. PubMed ID: 8982949
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report.
Wu S; Bai Z; Dong X; Yang D; Chen H; Hua J; Zhou L; Lv H
BMC Pediatr; 2019 Aug; 19(1):289. PubMed ID: 31438894
[TBL] [Abstract][Full Text] [Related]
39. Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked Adrenoleukodystrophy.
Schönfeld P; Reiser G
Aging Dis; 2016 Mar; 7(2):136-49. PubMed ID: 27114847
[TBL] [Abstract][Full Text] [Related]
40. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
